Glenmede Trust’s ClearOne Inc CLRO Stock Holding History

Glenmede Trust’s Portfolio CLRO Stock Details CLRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13	Closed	–	–	1412
2020 Q3	$0	Hold	13	–	–	﹤0.01%	2477
2020 Q2	$0	Buy	+13	New	+$362	﹤0.01%	2464

Other funds holding CLRO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Glenmede Trust's CLRO Position: Q4 2020 in Review

Glenmede Trust sold out of ClearOne Inc (CLRO) in Q4 2020, closing a stake of 13 shares.

Glenmede Trust first reported a position in CLRO in Q2 2020 and held it in 2 quarters. The position peaked at $0 in Q3 2020. 14 funds tracked by Wall St. Rank hold CLRO as of Q4 2020.

Glenmede Trust reported no remaining ClearOne Inc position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 13 ClearOne Inc shares in Q4 2020.
Glenmede Trust first reported a position in ClearOne Inc in Q2 2020 and held it in 2 quarters.
Glenmede Trust's ClearOne Inc position peaked at $0 in Q3 2020.
14 funds tracked by Wall St. Rank held ClearOne Inc as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.